Alpha-GPC in Your Pre-Workout: What the Studies Actually Measured

Why pre-workout formulas put alpha-GPC on the label

The pitch is a three-step chain. Step one: swallowing alpha-GPC raises blood choline. That part is solid; small human pharmacokinetic studies in healthy adults consistently show oral GPC lifts plasma choline within about an hour. Step two: choline is the building block of acetylcholine, the neurotransmitter your motor nerves use to tell muscle fibers to contract. That part is textbook physiology. Step three: therefore more alpha-GPC means harder contractions, more power, better sessions. That last step is the leap, and the leap is what the label is quietly selling.

There is also a commercial reason it earns shelf space: an ingredient that plays both the brain slot and the brawn slot lets a formulator write focus and power in the same paragraph. Marketing-efficient. Whether it is evidence-efficient can only be answered by skipping the mechanism story and measuring the endpoint: give people alpha-GPC, test their output. That has happened in exactly five human trials.

If you are new to the molecule itself (a choline compound your body also makes, studied mostly for cognition), start with our alpha-GPC hub, then come back for the gym-specific file.

The five human trials, all of them

Our research library indexes 144 alpha-GPC studies, every PMID verified against PubMed. Filter for athletic performance in humans and you get five. Not fifty. Five, and two of those tested blends where alpha-GPC shared the bottle with other actives. Here is the complete set, next to the two growth hormone studies: the whole hand at once.

The strength trial everyone quotes: 13 men, 6 days, 600 mg

In a double-blind, placebo-controlled crossover (a human RCT, top of the evidence ladder, bottom of the size ladder), 13 college-aged men took 600 mg of alpha-GPC daily for 6 days, and their lower-body isometric mid-thigh pull force improved versus placebo: a gain of 98.8 newtons against a 39.0 newton decline on placebo, p = 0.044. The upper-body test moved in the same direction without reaching significance (p = 0.127). That result is real, and it is also 13 people pulling on an immovable bar after six days of capsules: a promising pilot, not a proven effect.

The bigger trial that found less

Two years later, 48 healthy men were randomized to 7 days of alpha-GPC 500 mg, alpha-GPC 250 mg, caffeine 200 mg, or placebo, and the result sheet reads differently: no differences in isometric strength or psychomotor vigilance on any arm. The 250 mg group did improve countermovement-jump velocity and power, the 500 mg group did not, and the 500 mg group showed significantly lowered serum thyroid-stimulating hormone (p < 0.04). Read that pattern honestly: the lower dose moved one jump metric, the higher dose moved a thyroid marker instead of a muscle. Small studies often look exactly like this.

The only trial in women is also the outlier in design: a randomized crossover in 12 overweight or obese women found a single 1000 mg dose taken before sprint-interval exercise sped up heart-rate-variability and blood-pressure recovery afterwards (human RCT). Interesting recovery physiology, unreplicated, and not a strength outcome.

The blend problem: two trials cannot credit alpha-GPC at all

The remaining two trials tested cocktails. In one, 20 trained college-aged men took a single dose of a blend carrying alpha-GPC 500 mg alongside uridine monophosphate and DHA, 90 minutes before testing: no improvement in vertical jump, bench-press repetitions, or cognition versus placebo (Bunn 2018, human RCT, crossover). A clean null.

In the other, 30 trained male cyclists took 7 days of BCAAs 8 g plus L-citrulline 6 g plus alpha-GPC 300 mg, and their 20-km time-trial peak power rose (354 vs 322 watts, p = .003) while time to fatigue stretched from about 14.5 to almost 20 minutes (p = .001), with completion time and average power unchanged (Harrington 2023, human RCT, crossover). Encouraging numbers with a structural catch our library flags on the record itself: three actives, one result, zero ability to say which ingredient did what.

Your tub has the same problem: a pre-workout is a blend by definition, so even a genuinely great session cannot be pinned on the alpha-GPC line specifically. The blend trials admit this limit. Labels rarely do.

The growth hormone studies: real spikes, wrong conclusion

Search data says the growth hormone angle pulls people here, so let us report exactly what exists: two human studies, both acute, both small.

In 1992, researchers gave young and elderly volunteers GHRH, the releasing hormone that triggers growth hormone, with or without alpha-GPC, and alpha-GPC potentiated the growth hormone response in both groups, more strongly in the elderly (Ceda 1992). This was a non-randomized acute hormone-challenge study: a physiology probe, not an outcome trial.

In 2012, a double-blind randomized crossover in 8 healthy young men found a single 1000 mg dose of GPC raised plasma growth hormone at the 60-minute mark and raised free fatty acids and ketone bodies, markers of fat oxidation, at 120 minutes, while placebo changed nothing (Kawamura 2012).

Now the part the forum posts skip: a transient growth hormone pulse is not a muscle-gain result. Growth hormone also spikes when you sleep, sprint, or skip breakfast. A 60-minute blip in 8 men says nothing about hypertrophy, recovery, or body composition, and no trial has connected an alpha-GPC spike to any of those outcomes. Reporting the spike is science. Promising gains from it is fan fiction.

Doses and timing the trials actually used

We report protocols here, we do not prescribe them: what studies did is a fact, what you should do is a conversation with your doctor.

• Standalone athletic trials: 250 to 600 mg per day, taken daily for 6 to 7 days. Neither ran it as a single scoop 20 minutes before lifting.
• Acute studies: one 1000 mg dose. In the 8-man crossover, growth hormone peaked around 60 minutes after ingestion.
• Timing on record: the one blend trial that timed its dose gave it 90 minutes before testing, and the sprint study dosed before exercise without a head-to-head timing comparison.
• Timing folklore: no trial has compared timings against each other, so any exact take-it-N-minutes-out rule is community habit wearing a confident font.

The most useful move: flip your tub around and compare its alpha-GPC milligrams to the doses above. That one check tells you whether your formula is even in the neighborhood the trials tested. For the full protocol breakdown by goal, see our alpha-GPC dosage guide.

What this evidence does not show

The honest gaps matter more than the highlights:

• No long-term outcomes. There are no strength or muscle-growth outcome trials in healthy lifters beyond a week. The longest athletic protocol on record ran 7 days.
• Tiny samples. The studies span 8 to 48 participants. The flagship strength result is 13 people.
• Mostly one demographic. Four of the five performance trials enrolled only men, mostly college-aged. The single study in women measured recovery physiology, not strength. Everyone else is extrapolating.
• Nulls exist. One trial found nothing at all, and the largest standalone trial found no isometric strength difference at either dose.

None of this means the ingredient is fake. It means the honest label would read: one small positive strength pilot, one larger mixed trial, a plausible mechanism, no long-term outcomes. That sentence does not sell tubs, which is why you have never read it on one.

The caffeine stack question, answered from what is missing

Most pre-workouts pair alpha-GPC with caffeine, and stim-free formulas sell it as the polite replacement. So does the combination outperform caffeine alone? Nobody knows. No trial in the 144-study library has tested alpha-GPC plus caffeine against caffeine by itself. The closest the literature comes is the 48-man trial above, which used caffeine 200 mg as a separate comparison arm and never combined the two. The stack is community practice, which is fine as long as nobody calls it trial-proven. If you are sensitive to stimulants or take any medication, that is a doctor conversation before it is a checkout click.

The safety line every gym article skips

Short athletic trials reported alpha-GPC as well tolerated, with the thyroid signal above (lowered TSH at 500 mg per day in one 48-man trial) as the exception worth remembering. The long-term picture comes from two giant Korean cohorts that point in opposite directions, and we always show both: a 2021 analysis of over 12 million adults aged 50 and up (Lee 2021) associated prescription alpha-GPC use with a 43 to 46 percent higher 10-year stroke risk that rose with longer use, while a 2025 cohort of 508,107 patients with mild cognitive impairment (Kim 2025) found users progressed to dementia less often and did not reproduce the harm signal in key groups. Both are observational studies: they show associations, not causes, and neither can fully separate who gets prescribed a drug from what happens to them afterwards.

If you take thyroid medication or any prescription, manage a health condition, or are pregnant or nursing, talk to your doctor before adding alpha-GPC to anything. The complete safety file, both cohorts unpacked, lives in our alpha-GPC side effects guide.

Frequently asked questions